The role of von Willebrand factor (vWF) in thrombotic thrombocytopenic purpura (TTP) and the hemolytic-uremic syndrome (HUS)
- PMID: 2191307
The role of von Willebrand factor (vWF) in thrombotic thrombocytopenic purpura (TTP) and the hemolytic-uremic syndrome (HUS)
Similar articles
-
Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).Am J Hematol. 1996 Dec;53(4):213-20. doi: 10.1002/(SICI)1096-8652(199612)53:4<213::AID-AJH1>3.0.CO;2-0. Am J Hematol. 1996. PMID: 8948657
-
Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.Clin Haematol. 1986 May;15(2):413-42. Clin Haematol. 1986. PMID: 3524932 Review.
-
Pathophysiology and treatment of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS).Int J Hematol. 2000 Jun;71(4):320-7. Int J Hematol. 2000. PMID: 10905050 Review.
-
Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.Am J Med. 1989 Sep;87(3N):9N-15N. Am J Med. 1989. PMID: 2486537
-
von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.Transfus Med Rev. 1990 Apr;4(2):163-8. doi: 10.1016/s0887-7963(90)70261-1. Transfus Med Rev. 1990. PMID: 2134624 Review. No abstract available.
Cited by
-
Platelet adhesion and aggregate formation controlled by immobilised and soluble VWF.BMC Mol Cell Biol. 2020 Sep 11;21(1):64. doi: 10.1186/s12860-020-00309-7. BMC Mol Cell Biol. 2020. PMID: 32917131 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous